Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A F Boyne

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
The Journal of Cell Biology|December 1, 1974
Effects of calcium-containing fixation solutions on cholinergic synaptic vesiclesA F Boyne, T P Bohan, T H Williams
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|September 1, 1984
Novel secretory granule morphology in physically fixed pancreatic isletsR W Dudek, A F Boyne, T M Charles
The Biochemical Journal|April 1, 1974
Adenosine triphosphate. A constituent of cholinergic synaptic vesiclesM J Dowdall, A F Boyne, V P Whittaker
Toxicology and Applied Pharmacology|January 1, 1989
The reversible carbamate, (-)physostigmine, reduces the size of synaptic end plate lesions induced by sarin, an irreversible organophosphateM Kawabuchi, A F Boyne, S S Deshpande, et al.
Experimental Neurology|July 1, 1985
Comparison of the ultrastructural myopathy induced by anticholinesterase agents at the end plates of rat soleus and extensor musclesC K Meshul, A F Boyne, S S Deshpande, et al.
Synapse (New York, N.Y.)|January 1, 1988
Enantiomer (+)physostigmine prevents organophosphate-induced subjunctional damage at the neuromuscular synapse by a mechanism not related to cholinesterase carbamylationM Kawabuchi, A F Boyne, S S Deshpande, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|December 1, 1985
Multiple actions of anticholinesterase agents on chemosensitive synapses: molecular basis for prophylaxis and treatment of organophosphate poisoningE X Albuquerque, S S Deshpande, M Kawabuchi, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
The Journal of Cell Biology|December 1, 1974
Effects of calcium-containing fixation solutions on cholinergic synaptic vesiclesA F Boyne, T P Bohan, T H Williams
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|September 1, 1984
Novel secretory granule morphology in physically fixed pancreatic isletsR W Dudek, A F Boyne, T M Charles
The Biochemical Journal|April 1, 1974
Adenosine triphosphate. A constituent of cholinergic synaptic vesiclesM J Dowdall, A F Boyne, V P Whittaker
Toxicology and Applied Pharmacology|January 1, 1989
The reversible carbamate, (-)physostigmine, reduces the size of synaptic end plate lesions induced by sarin, an irreversible organophosphateM Kawabuchi, A F Boyne, S S Deshpande, et al.
Experimental Neurology|July 1, 1985
Comparison of the ultrastructural myopathy induced by anticholinesterase agents at the end plates of rat soleus and extensor musclesC K Meshul, A F Boyne, S S Deshpande, et al.
Synapse (New York, N.Y.)|January 1, 1988
Enantiomer (+)physostigmine prevents organophosphate-induced subjunctional damage at the neuromuscular synapse by a mechanism not related to cholinesterase carbamylationM Kawabuchi, A F Boyne, S S Deshpande, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|December 1, 1985
Multiple actions of anticholinesterase agents on chemosensitive synapses: molecular basis for prophylaxis and treatment of organophosphate poisoningE X Albuquerque, S S Deshpande, M Kawabuchi, et al.
Pageof 2